•
KO
KOD
Kodiak Sciences Inc Common Stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
1.63B
Volume
804.37K
52W High
$31.18
52W Low
$1.92
Open
$27.55
Prev Close
$26.71
Day Range
27.29 - 29.49
About Kodiak Sciences Inc Common Stock
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Latest News
Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday
Benzinga•Sep 25
Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type
GlobeNewswire Inc.•Jan 10
Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
Zacks Investment Research•Jun 20
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
Zacks Investment Research•Jun 14
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks Investment Research•May 16
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Zacks Investment Research•Apr 4
Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus
Zacks Investment Research•Apr 1
Take the Zacks Approach to Beat the Market: NVIDIA, Dell, Modine in Focus
Zacks Investment Research•Apr 1